
Please find important resources related to the administration and management of immune-mediated adverse events (imAEs) related to BOTENSILIMAB (BOT) plus BALSTILIMAB (BAL) Immunotherapy.
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis